<link type="text/css" rel="stylesheet" href="{{params.filesPath + 'css/styles.css'}}" />

<div class="container">
    <div class="container-inner">
        <div class="container-main">
            <div class="main-content">
                <div class="col-center floatl">
                    <div id="node-1026091" class="node odd full-node node-type-cancer_genome_project">
  <div class="node-inner">
    <div class="post-box">
      <div class="post">


        <div id="cgp-project">
          <div class="cgp-subject floatl full" style="padding-bottom: 0.25em;">
            <div class="cgp-flag-block">
              <div class="cgp-flag"><img class="cpg-flag" src="../../../../files/flags/fr.gif" /></div><div class="cgp-flag-country">France</div>            </div>

    <!-- Tumor type and molecular subtype -->
            <div class="floatl cgp-tumor-type" style="margin-bottom:0px;width:535px ">
              <div class="floatl">
              Lymphoproliferative Syndrome - B-Cell Prolymphocytic Leukemia</div>
         <div id = "project-ids" class="floatl datacode">
              <ul id = "project-ids-list">
              <li class=datacodelinks><a href="https://dcc.icgc.org/projects?filters=%7B%22project%22%3A%7B%22id%22%3A%7B%22is%22%3A%5B%22BPLL-FR%22%5D%7D%7D%7D" class="project-data-extra ext" target="_blank">BPLL-FR</a></li>
              </ul></div>
            </div>

      <div class="floatl cgp-org-sys-icon" style="margin-bottom:0px;padding-left:7px;">

        <img class="cgp-org-sys-icon" src="../../../../files/org_sys/hem.png"/>      </div>


          </div>
          <!--
          <div class="span-12 floatl cgp-tumor-type cgp-project-status" style="line-height:40%;">
           </div>-->

<!-- Funding Organizations -->

<div class = "tab floatl whitetab">Project Profile</div>
<div class = "tab floatl bluetab">
                          <a href="https://dcc.icgc.org/projects?filters=%7B%22project%22%3A%7B%22id%22%3A%7B%22is%22%3A%5B%22BPLL-FR%22%5D%7D%7D%7D" class="project-data-extra ext" target="_blank">Project Data »</a></div>
          <div class="cpg-funding floatl full">
            <div id="cgp-projects-left" class="cgp-region floatl">
              <div class="spacing-top full blue font-large">Funding Organizations</div>
<!-- Research Organizations -->
<div class="cgp-projects-summary">
              <div class="view view-cgp-ins-view view-id-cgp_ins_view view-display-id-page_2 view-dom-id-1">



      <div class="view-content">


<table class="views-table cols-7">
  <tbody>
          <tr>
        <td class="cgp-countrytxt">France:</td>
        <!--<td class="cgp-countrytxt"></td>-->
    <td class="">

<a target="_blank" href="http://www.e-cancer.fr/" title="Institut National du Cancer (INCa)">Institut National du Cancer (INCa)</a></td></tr>
<tr><td colspan="2" style="line-height:0.5em;">
<a target="_blank" href="http://www.e-cancer.fr/" title="Institut National du Cancer (INCa)"><img class="cgp-logo cgp-logo-funding" src="../../../../files/imagefield_uploads/uploaded_logo/nouveau-logo-inca_2015%20-%20300dpi.jpg"/></a>
</td>
</tr>
      <tr>
        <td class="cgp-countrytxt">France:</td>
        <!--<td class="cgp-countrytxt"></td>-->
    <td class="">

<a target="_blank" href="https://itcancer.aviesan.fr/" title="Instituts Thématiques Multi-Organismes (ITMO Cancer) / INSERM">Instituts Thématiques Multi-Organismes (ITMO Cancer) / INSERM</a></td></tr>
<tr><td colspan="2" style="line-height:0.5em;">
<a target="_blank" href="https://itcancer.aviesan.fr/" title="Instituts Thématiques Multi-Organismes (ITMO Cancer) / INSERM"><img class="cgp-logo cgp-logo-funding" src="../../../../files/imagefield_uploads/uploaded_logo/Inserm.jpg"/></a>
</td>
</tr>
  </tbody>
</table>
    </div>






</div> </div>

              <div class="spacing-top full floatl blue font-large">Research Organizations</div>
              <div class="view view-cgp-ins-view view-id-cgp_ins_view view-display-id-page_1 view-dom-id-2">



      <div class="view-content">
      <div  class="cgp-res-grid crg_img"><a target="_blank" href="http://www.gustaveroussy.fr/" title="Institut Gustave Roussy"><img class="cgp-logo" src="../../../../files/imagefield_uploads/uploaded_logo/Gustave%20Roussy.jpg" title="Institut Gustave Roussy"/></a><a target="_blank" href="http://www.gustaveroussy.fr/" title="Institut Gustave Roussy"><span class="cgp-res-grid-title">France: Institut Gustave Roussy</span></a></div>
    </div>






</div>               <div class="blue full floatl font-large" style="margin-top:12px;">Research Activities</div>
<!-- Publication Policy -->

              <div class="cgp-projects-region floatl spacing-top"><img class="css-projects-region" src="../../../../files/icgc/dat.png"/>
                <div class="eighty floatl">
                  <div class="cgp-region-subject blue">Publication Policy</div>
                  <hr class="blue"/>
                </div>
<div class="floatl padl10" style="width:100%">            <span class="font-small">
                  <div class="view view-cgp-docs-view view-id-cgp_docs_view view-display-id-page_1 view-dom-id-3">



      <div class="view-content">


    <table class="views-table cols-10" style="margin-bottom:1em;">
  <tbody>



<tr class="">
    <td class="cgp-countrytxt">
    1:&nbsp;&nbsp;</td>

    <td class="floatl">ICGC Goals, Structure, Policies and Guidelines Section E.3 - Publication Policy<a  target="_blank" href="../../../goals-structure-policies-guidelines/e3-publication-policy.html"> HTML&nbsp;<img src="../../../../sites/all/themes/daco_theme_2/images/internalicon_small.gif"></a><br/>    <span class="media-gr"></span>
</td>

</tr>




<tr class="">
    <td class="cgp-countrytxt">
    2:&nbsp;&nbsp;</td>

    <td class="floatl">Template Letters to Facilitate Communications<a  target="_blank" href="../../../cgp-template-letters.html"> HTML&nbsp;<img src="../../../../sites/all/themes/daco_theme_2/images/internalicon_small.gif"></a><br/>    <span class="media-gr">to ensure appropriate dialogue between data users and generators and for authors to contact ICGC members and editors</span>
</td>

</tr>

      </tbody>
</table>

    </div>






</div>                   </span>
                       </div>
              </div>

<!-- Clinic and Pathology -->


              <div class="cgp-projects-region floatl spacing-top"><img class="css-projects-region" src="../../../../files/icgc/medical.png"/>
                <div class="eighty floatl">
                  <div class="cgp-region-subject blue">Clinic &amp; Pathology</div>
                      <hr class="blue"/>

                </div>
<div class="floatl padl10" style="width:100%">                 <div class="view view-cgp-ins-view view-id-cgp_ins_view view-display-id-page_3 view-dom-id-3">



      <div class="view-content">

<table class="views-table cols-8">
  <tbody>
      <tr class="">
<td class="cgp-countrytxt" style="width:50px">    France: </td>

    <td class="">Institut Gustave Roussy</td>

</tr>

      </tbody>
</table>
    </div>






</div>                                    <span class="font-small"><p>B-cell prolymphocytic leukemia (B-PLL) is a neoplasm of B prolymphocytes affecting the peripheral blood, bone marrow and spleen. Prolymphocytes must exceed 55% of lymphoid cells in the blood. B-PLL is an extremely rare disease, with little knowledge about the cell of origin, and the genetic abnormalities. We have collected cells from 14 patients, with a confirmed diagnosis of B-PLL by revised morphology (3 reviewers). For all those patients, we have clinical and biological data, including age, sex, lymphocytosis, Hb, Platelets, date of diagnosis, date of treatment, type of treatment, immunophenotype, cytogenetics, IGHV status. </p>
</span><span class="font-small">
<div class="view view-cgp-docs-view view-id-cgp_docs_view view-display-id-page_1 view-dom-id-5">









</div>                   </span></div>
              </div>

<!-- Sequencing and Analysis -->

              <div class="cgp-projects-region floatl spacing-top"><img class="css-projects-region" src="../../../../files/icgc/dna.png"/>
                <div class="eighty floatl">
                  <div class="cgp-region-subject blue">Sequencing &amp; Analysis</div>
                  <hr class="blue"/>
                </div>
<div class="floatl padl10" style="width:100%">  <div class="view view-cgp-ins-view view-id-cgp_ins_view view-display-id-page_3 view-dom-id-4">



      <div class="view-content">

<table class="views-table cols-8">
  <tbody>
      <tr class="">
<td class="cgp-countrytxt" style="width:50px">    France: </td>

    <td class="">Institut Gustave Roussy</td>

</tr>

      </tbody>
</table>
    </div>






</div>
                                  <span class="font-small"><p>We used sorted CD19+ tumor cells (and CD5+ when appropriate) and nontumor (CD3+) cells to extract DNA from exome capture with the SureSelect V4 Mb All Exon Kit (Agilent Technologies) following the standard protocols. We performed paired-end sequencing (100 bp) using HiSeq2000 sequencing instruments at IGR. </p>
</span><span class="font-small">
                  <div class="view view-cgp-docs-view view-id-cgp_docs_view view-display-id-page_1 view-dom-id-5">









</div>                   </span></div>
              </div>

<!-- Complementary Studies -->

              <div class="cgp-projects-region floatl spacing-top"><img class="css-projects-region" src="../../../../files/icgc/compstudies.png"/>
                <div class="floatl eighty">
                  <div class="cgp-region-subject blue">Complementary Studies</div>
                  <hr class="blue"/>
                </div>
<div class="floatl padl10" style="width:100%">             <div class="view view-cgp-ins-view view-id-cgp_ins_view view-display-id-page_3 view-dom-id-4">









</div>                        <span class="font-small"></span><span class="font-small">
                  <div class="view view-cgp-docs-view view-id-cgp_docs_view view-display-id-page_1 view-dom-id-5">









</div>                   </span></div>
              </div>

<!-- Data storage, Analysis and Management -->

              <div class="cgp-projects-region floatl spacing-top"><img class="css-projects-region" src="../../../../files/icgc/compserver.png"/>
                <div class="eighty floatl">
                  <div class="cgp-region-subject blue">Data Storage, Analysis &amp; Management</div>
                  <hr class="blue"/>
                </div>
<div class="floatl padl10" style="width:100%">                         <div class="view view-cgp-ins-view view-id-cgp_ins_view view-display-id-page_3 view-dom-id-5">



      <div class="view-content">

<table class="views-table cols-8">
  <tbody>
      <tr class="">
<td class="cgp-countrytxt" style="width:50px">    France: </td>

    <td class="">Institut Gustave Roussy</td>

</tr>

      </tbody>
</table>
    </div>






</div>                 <span class="font-small"><p>We mapped reads from the Illumina sequencing to the reference genome hg19 using the Burrows-Wheeler Aligner (BWA) alignment tool version 0.5.9. PCR duplicates were removed using SAMtools (0.1.18). The detection of candidate somatic mutations was performed as previously described (Damm et al, Cancer Discovery, 2014;4:1088-1101) with minor modification. Briefly, the number of the reads containing single-nucleotide variations (SNV) and indels in both tumor and reference samples was enumerated using SAMtools, and the null hypothesis of equal allele frequencies between tumor and reference was tested using the two-tailed Fisher exact test. For candidate somatic mutations, those variants were adopted as candidate mutations whose P value was &lt;0.01 and the allele frequency was &lt;0.1 in the reference sample. </p>
</span><span class="font-small">
                  <div class="view view-cgp-docs-view view-id-cgp_docs_view view-display-id-page_1 view-dom-id-5">









</div>                   </span></div>
              </div>



</div>


<!-- Project Summary -->
            <div id="cgp-projects-right" class="cgp-region floatl">
                            <div class="spacing-top blue font-large">Project Summary</div>
              <div class="cgp-projects-summary floatl"><p>Prolymphocytic B-cell leukaemia is a rare blood cancer characterised by the presence of B prolymphocytes in peripheral blood, bone marrow and spleen. This is an aggressive blood cancer that presents poor response to treatment.<br />
Prolymphocytic B-cell leukemia samples are being analyzed for the presence of somatic mutations using exome sequencing. The clonal organization of the tumor and the cell of origin will be determined using a combination of resequencing and cellular biology approaches. </p>
              </div>
                              <div class="spacing-top blue font-large">Principal Investigators</div>
              <div class="cgp-projects-summary floatl"><p>Olivier Bernard<br />
Florence Nguyen Khac</p>
              </div>
                                          </div>

          </div>
        </div>
      </div>
      <p>
              </p>
            </div>
      </div>
</div>

                            </div>
            </div>
                        <!-- content bottom -->
                        <div id="main-content-bottom" class="clear">                             <div id="last-modified-nav">
                                <div class="date_posted">
                                                                            Last updated on:  6 June 2016                                </div>
                            </div>
                        </div>
                    </div>
                </div>

    </div>
</div>
